94 related articles for article (PubMed ID: 886551)
1. Antirheumatic drugs, the ESR, and the hypohistidinemia of rheumatoid arthritis.
Gerber DA
J Rheumatol; 1977; 4(1):40-5. PubMed ID: 886551
[TBL] [Abstract][Full Text] [Related]
2. Low free serum histidine concentration in rheumatoid arthritis. A measure of disease activity.
Gerber DA
J Clin Invest; 1975 Jun; 55(6):1164-73. PubMed ID: 1079527
[TBL] [Abstract][Full Text] [Related]
3. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
Forster PJ; McConkey B
Q J Med; 1986 Jan; 58(225):29-42. PubMed ID: 2871585
[TBL] [Abstract][Full Text] [Related]
4. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
Rau R; Schleusser B; Herborn G; Karger T
J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
[TBL] [Abstract][Full Text] [Related]
5. [Use of indomethacin in combination with other antirheumatic drugs in the therapy of chronic inflammatory rheumatism].
Bossa G; Giordano M
Clin Ter; 1972 Aug; 62(3):205-11. PubMed ID: 5081151
[No Abstract] [Full Text] [Related]
6. Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response.
Situnayake RD; McConkey B
J Rheumatol; 1990 Oct; 17(10):1268-73. PubMed ID: 1979349
[TBL] [Abstract][Full Text] [Related]
7. The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis.
McConkey B; Crockson RA; Crockson AP; Wilkinson AR
Q J Med; 1973 Oct; 42(168):785-91. PubMed ID: 4370457
[No Abstract] [Full Text] [Related]
8. [Results of clinical management of patients with very active rheumatoid arthritis. Comparative demonstration of therapy with non-steroid antiphlogistics, gold salts and the immunosuppressive agents proresid and endoxan].
Wawrzyńska-Pagowska J; Graff-Wróblewska T; Juszczyk T; Michalski J; Pakula A; Piotrowska D; Scislowska M
Z Rheumaforsch; 1973; 32(1):32-9. PubMed ID: 4693416
[No Abstract] [Full Text] [Related]
9. Long-term treatment of rheumatoid arthritis with fenclofenac or gold: a controlled, single blind trial comparing clinical and biochemical parameters.
Lund B; Graae A; Sonne I; Andersen RB
Eur J Rheumatol Inflamm; 1983; 6(3):279-87. PubMed ID: 6391933
[TBL] [Abstract][Full Text] [Related]
10. Serum histidine in rheumatoid arthritis: changes induced by antirheumatic drug therapy.
Pickup ME; Dixon JS; Lowe JR; Wright V
J Rheumatol; 1980; 7(1):71-6. PubMed ID: 7354471
[TBL] [Abstract][Full Text] [Related]
11. Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis.
Dasgupta B; Corkill M; Kirkham B; Gibson T; Panayi G
J Rheumatol; 1992 Jan; 19(1):22-5. PubMed ID: 1556695
[TBL] [Abstract][Full Text] [Related]
12. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE;
J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
[TBL] [Abstract][Full Text] [Related]
13. Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein.
Cohick CB; Furst DE; Quagliata S; Corcoran KA; Steere KJ; Yager JG; Lindsley HB
J Lab Clin Med; 1994 May; 123(5):721-7. PubMed ID: 8195678
[TBL] [Abstract][Full Text] [Related]
14. Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis.
Syngle A; Vohra K; Kaur L; Sharma S
Scand J Rheumatol; 2009; 38(1):15-22. PubMed ID: 18766955
[TBL] [Abstract][Full Text] [Related]
15. Relationship between erythrocyte sedimentation rate and serum C-reactive protein in rheumatoid arthritis.
Walsh L; Davies P; McConkey B
Ann Rheum Dis; 1979 Aug; 38(4):362-3. PubMed ID: 496450
[TBL] [Abstract][Full Text] [Related]
16. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone.
Pincus T; Marcum SB; Callahan LF
J Rheumatol; 1992 Dec; 19(12):1885-94. PubMed ID: 1294735
[TBL] [Abstract][Full Text] [Related]
17. [Thoughts on the so-called combined medicinal therapy of rheumatoid arthritis, with special reference to a goldhormone combination].
ROBECCHI A
Minerva Med; 1957 Aug; 48(69):2713-9. PubMed ID: 13483272
[No Abstract] [Full Text] [Related]
18. Cyclophosphamide therapy for rheumatoid arthritis.
Smyth CJ; Bartholomew BA; Mills DM; Steigerwald JC; Strong SJ; Recart S
Arch Intern Med; 1975 Jun; 135(6):789-93. PubMed ID: 1093503
[TBL] [Abstract][Full Text] [Related]
19. In vivo effects of antirheumatic drugs on neutral collagenolytic proteases in human rheumatoid arthritis cartilage and synovium.
Martel-Pelletier J; Cloutier JM; Pelletier JP
J Rheumatol; 1988 Aug; 15(8):1198-204. PubMed ID: 3054093
[TBL] [Abstract][Full Text] [Related]
20. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
Montecucco C; Caporali R; Caprotti P; Caprotti M; Notario A
J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
